Alkermes

is an Ireland-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of neuroscience diseases...
Read more
Alkermes Chairman & CEO: Richard Pops

Chairman & CEO

Richard Pops

CEO Approval Rating

61/100

Annual Revenue
$1.6B
Employees
2,050
Funding
$250M
Acquisitions
3
Investments
3

Alkermes Competitors

1Lundbeck
2Otsuka Pharmaceutical
3Merck
4Quickbeam
5Polygen
6Taiwan Liposome Company, Ltd.
7VOI
8BioTech Decisions
9SPG - Clinical Resource Network

Trending Companies